CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing
Proceedings of the National Academy of Sciences · 26.09.2023 · 120 (39)
DOI: 10.1073/pnas.2302878120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.09.2023. Verfasst von Zheng Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298. Hauptthemen laut MEDLINE: Carnitine O-Palmitoyltransferase, Neoplasms. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH/NCI, Department of Defense.
Abstract (Originalsprache)
Although tumor-intrinsic fatty acid β-oxidation (FAO) is implicated in multiple aspects of tumorigenesis and progression, the impact of this metabolic pathway on cancer cell susceptibility to immunotherapy remains unknown. Here, we report that cytotoxicity of killer T cells induces activation of FAO and upregulation of carnitine palmitoyltransferase 1A (CPT1A), the rate-limiting enzyme of FAO in cancer cells. The repression of CPT1A activity or expression renders cancer cells more susceptible to destruction by cytotoxic T lymphocytes. Our mechanistic studies reveal that FAO deficiency abrogates the prosurvival signaling in cancer cells under immune cytolytic stress. Furthermore, we identify T cell–derived IFN-γ as a major factor responsible for induction of CPT1A and FAO in an AMPK-dependent manner, indicating a dynamic interplay between immune effector cells and tumor targets. While cancer growth in the absence of CPT1A remains largely unaffected, established tumors upon FAO inhibition become significantly more responsive to cellular immunotherapies including chimeric antigen receptor-engineered human T cells. Together, these findings uncover a mode of cancer resistance and immune editing that can facilitate immune escape and limit the benefits of immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
- Department of Biochemistry, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
- Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
- Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
- Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
- Hunter Holmes McGuire VA Medical Center, Richmond, VA 23249.
ORCID-Profile: Zheng Liu, David L Drum, Jinyang Cai, Syed Shah, Paul B Fisher, Chunqing Guo, Xiang-Yang Wang
Förderung
- NCI NIH HHS
- NIH/NCI
- Department of Defense
Zitieren
APA
Liu, Z., Liu, W., Wang, W., Ma, Y., Wang, Y., Drum, D. L., Cai, J., Blevins, H., Lee, E., Shah, S., Fisher, P. B., Wang, X., Fang, X., Guo, C., & Wang, X. Y. (2023). CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing. Proceedings of the National Academy of Sciences, 120(39). https://doi.org/10.1073/pnas.2302878120
Vancouver
Liu Z, Liu W, Wang W, Ma Y, Wang Y, Drum DL, et al. CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing. Proceedings of the National Academy of Sciences. 2023;120(39). doi:10.1073/pnas.2302878120
BibTeX
@article{Liu2023,
author = {Liu, Zheng and Liu, Wenjie and Wang, Wei and Ma, Yibao and Wang, Yufeng and Drum, David L and Cai, Jinyang and Blevins, Hallie and Lee, Eun and Shah, Syed and Fisher, Paul B and Wang, Xinhui and Fang, Xianjun and Guo, Chunqing and Wang, Xiang-Yang},
title = {CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {39},
doi = {10.1073/pnas.2302878120}
}
EUVIMED